Global In Vitro Diagnostics (IVD) Market Report: 2012 Edition- Koncept Analytics – Video




Global In Vitro Diagnostics (IVD) Market Report: 2012 Edition- Koncept Analytics
In-vitro diagnostic (IVD) tests are performed to examine specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information concerning physiological or pathological state, or concerning congenital abnormality. IVD accounts for a major share of the global diagnostics market, and the same continues to increase irrespective of the unfavorable market conditions such as the recent worldwide economic recession. On the basis of technology, clinical biochemistry dominates the global IVD market, followed by immunoassays and molecular biology. On the basis of customer segments, clinical laboratories represent the largest segment, followed by point-of-care and research laboratories. Point-of-care customer segment offers diagnostic services at or near the site of the patient. Glucose monitoring recorded the largest share in the point-of-care segment. Globally, North America, Europe and Japan are the largest IVD markets. In Europe, the largest markets are Germany, France and Italy. India, China and Brazil are the emerging IVD markets which are projected to register high growth in the coming years. The main drivers of the IVD industry discussed in this report are increasing ageing population, growing diabetic population, high insurance density and low vitamin D penetration. In addition, the report also identifies the key market trends which include significant merger and acquisition activities, coupled with the ...

By: Vikas Gupta

Read the original:
Global In Vitro Diagnostics (IVD) Market Report: 2012 Edition- Koncept Analytics - Video

Related Posts

Comments are closed.